Revolution Medicines (RVMD) - News Mentions

Sign up to add (RVMD) to your portfolio and access more historical data.

0 100%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 1 0%
Gilead Sciences
Gilead Sciences
GILD		 0 0%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Rating of “Buy” by Analysts
January 2
Y Intercept Hong Kong Ltd Makes New $247,000 Investment in Revolution Medicines, Inc. (NASDAQ:RVMD)
December 19
Captrust Financial Advisors Boosts Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
December 14
Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $63.67 Consensus Target Price from Analysts
December 13
One Revolution Medicines Insider Raised Their Stake In The Previous Year
December 11
Verition Fund Management LLC Buys New Stake in Revolution Medicines, Inc. (NASDAQ:RVMD)
December 11
Revolution Medicines (NASDAQ:RVMD) Shares Gap Up on Insider Buying Activity
December 10
Revolution Medicines, Inc. (NASDAQ:RVMD) Director Thilo Schroeder Acquires 1,304,347 Shares
December 10
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $9.80 Million Stock Position in Revolution Medicines, Inc. (NASDAQ:RVMD)
December 9
Equities Analysts Offer Predictions for RVMD FY2024 Earnings
December 6
Revolution Medicines (NASDAQ:RVMD) Price Target Raised to $71.00
December 6
Revolution Medicines (NASDAQ:RVMD) Given New $72.00 Price Target at HC Wainwright
December 6
Revolution Medicines (NASDAQ:RVMD) Sees Unusually-High Trading Volume Following Analyst Upgrade
December 5
Revolution Medicines Completes Sale of Common Stock and Pre-Funded WarrantsOn December 5, 2024, Revolution Medicines, Inc. concluded the sale of its common stock and pre-funded warrants following an underwriting agreement entered into on December 3,
December 5
Revolution Medicines Announces Closing of Upsized Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares
December 5
Revolution Medicines’ (RVMD) “Buy” Rating Reaffirmed at Needham & Company LLC
December 5

Month over Month

Est. daily news mentions.

Dec 2024 1
Nov 2024 0
Oct 2024 1
Sep 2024 0
Aug 2024 0

How often is Revolution Medicines mentioned in the news?

Revolution Medicines was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Revolution Medicines performing compared to its industry peers?

Revolution Medicines underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Revolution Medicines in the last month?

Revolution Medicines' was mentioned in fewer articles yesterday, compared to the same day last month.

Why is it important to track news mentions for Revolution Medicines?

By monitoring mentions in the news for Revolution Medicines, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Revolution Medicines, ultimately improving their investment strategies.

Sign up and get more insights on Revolution Medicines.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact